HK1205104A1 - Novel neurokinin receptor antagonist compounds - Google Patents
Novel neurokinin receptor antagonist compoundsInfo
- Publication number
- HK1205104A1 HK1205104A1 HK15105430.0A HK15105430A HK1205104A1 HK 1205104 A1 HK1205104 A1 HK 1205104A1 HK 15105430 A HK15105430 A HK 15105430A HK 1205104 A1 HK1205104 A1 HK 1205104A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor antagonist
- antagonist compounds
- neurokinin receptor
- novel neurokinin
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261601902P | 2012-02-22 | 2012-02-22 | |
| PCT/EP2013/053319 WO2013124286A1 (en) | 2012-02-22 | 2013-02-20 | Novel neurokinin 1 receptor antagonist compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1205104A1 true HK1205104A1 (en) | 2015-12-11 |
Family
ID=48325586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15105430.0A HK1205104A1 (en) | 2012-02-22 | 2015-06-08 | Novel neurokinin receptor antagonist compounds |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9181259B2 (xx) |
| EP (1) | EP2817312B1 (xx) |
| JP (1) | JP6111274B2 (xx) |
| KR (1) | KR20140122764A (xx) |
| CN (1) | CN104245702B (xx) |
| AU (1) | AU2013224181A1 (xx) |
| CA (1) | CA2864440A1 (xx) |
| DK (1) | DK2817312T3 (xx) |
| ES (1) | ES2568909T3 (xx) |
| HK (1) | HK1205104A1 (xx) |
| MX (1) | MX2014010012A (xx) |
| PL (1) | PL2817312T3 (xx) |
| RU (1) | RU2631319C2 (xx) |
| SG (1) | SG11201404880UA (xx) |
| TW (1) | TW201339161A (xx) |
| WO (1) | WO2013124286A1 (xx) |
| ZA (1) | ZA201405959B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2817312T3 (pl) * | 2012-02-22 | 2016-08-31 | Leo Pharma As | Nowe związki będące antagonistami receptora neurokininy 1 |
| SG11201501867UA (en) | 2012-10-11 | 2015-04-29 | Nerre Therapeutics Ltd | Novel uses |
| US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| WO2015024203A1 (en) * | 2013-08-20 | 2015-02-26 | Leo Pharma A/S | Novel neurokinin 1 receptor antagonist compounds ii |
| US10744185B2 (en) * | 2015-11-09 | 2020-08-18 | Ngm Biopharmaceuticals, Inc. | Methods of using variants of FGF19 polypeptides for the treatment of pruritus |
| JP2019519592A (ja) * | 2016-06-29 | 2019-07-11 | メンロ セラピューティクス インコーポレイテッド | 様々な掻痒状態を処置するためのニューロキニン−１アンタゴニストの使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9923748D0 (en) * | 1999-10-07 | 1999-12-08 | Glaxo Group Ltd | Chemical compounds |
| GB0025354D0 (en) | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
| GB0108595D0 (en) | 2001-04-05 | 2001-05-23 | Glaxo Group Ltd | Chemical compounds |
| GB0203020D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| UA77515C2 (en) * | 2002-04-04 | 2006-12-15 | Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity | |
| CA2590039A1 (en) * | 2004-12-14 | 2006-06-22 | Merck & Co., Inc. | Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| EP2129381A1 (en) | 2007-01-24 | 2009-12-09 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
| WO2009002770A1 (en) | 2007-06-22 | 2008-12-31 | Merck & Co., Inc. | 6.5-pyrrolopiperidine tachykinin receptor antagonists |
| PL2817312T3 (pl) * | 2012-02-22 | 2016-08-31 | Leo Pharma As | Nowe związki będące antagonistami receptora neurokininy 1 |
-
2013
- 2013-02-20 PL PL13720801T patent/PL2817312T3/pl unknown
- 2013-02-20 CA CA2864440A patent/CA2864440A1/en not_active Abandoned
- 2013-02-20 EP EP13720801.3A patent/EP2817312B1/en not_active Not-in-force
- 2013-02-20 JP JP2014558082A patent/JP6111274B2/ja not_active Expired - Fee Related
- 2013-02-20 ES ES13720801T patent/ES2568909T3/es active Active
- 2013-02-20 KR KR1020147026352A patent/KR20140122764A/ko not_active Application Discontinuation
- 2013-02-20 DK DK13720801.3T patent/DK2817312T3/en active
- 2013-02-20 RU RU2014138032A patent/RU2631319C2/ru not_active IP Right Cessation
- 2013-02-20 CN CN201380021175.4A patent/CN104245702B/zh not_active Expired - Fee Related
- 2013-02-20 AU AU2013224181A patent/AU2013224181A1/en not_active Abandoned
- 2013-02-20 MX MX2014010012A patent/MX2014010012A/es unknown
- 2013-02-20 US US14/380,078 patent/US9181259B2/en not_active Expired - Fee Related
- 2013-02-20 WO PCT/EP2013/053319 patent/WO2013124286A1/en active Application Filing
- 2013-02-20 SG SG11201404880UA patent/SG11201404880UA/en unknown
- 2013-02-21 TW TW102106062A patent/TW201339161A/zh unknown
-
2014
- 2014-08-14 ZA ZA2014/05959A patent/ZA201405959B/en unknown
-
2015
- 2015-06-08 HK HK15105430.0A patent/HK1205104A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140122764A (ko) | 2014-10-20 |
| CN104245702B (zh) | 2016-09-14 |
| PL2817312T3 (pl) | 2016-08-31 |
| AU2013224181A1 (en) | 2014-10-02 |
| RU2014138032A (ru) | 2016-04-10 |
| EP2817312B1 (en) | 2016-02-17 |
| ZA201405959B (en) | 2016-08-31 |
| WO2013124286A1 (en) | 2013-08-29 |
| CN104245702A (zh) | 2014-12-24 |
| CA2864440A1 (en) | 2013-08-29 |
| EP2817312A1 (en) | 2014-12-31 |
| DK2817312T3 (en) | 2016-04-11 |
| ES2568909T3 (es) | 2016-05-05 |
| US9181259B2 (en) | 2015-11-10 |
| SG11201404880UA (en) | 2014-09-26 |
| MX2014010012A (es) | 2014-09-12 |
| US20150018345A1 (en) | 2015-01-15 |
| JP2015511240A (ja) | 2015-04-16 |
| TW201339161A (zh) | 2013-10-01 |
| RU2631319C2 (ru) | 2017-09-21 |
| JP6111274B2 (ja) | 2017-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1252279A1 (zh) | 5- ht3受體拮抗劑 | |
| HK1203191A1 (en) | P2x4 receptor antagonist p2x4 | |
| PL2794626T6 (pl) | Związki antagonistyczne E-selektyny | |
| GB201213700D0 (en) | Receptor antagnists II | |
| EP2665707A4 (en) | Mineralocorticoid receptor antagonists | |
| HK1205104A1 (en) | Novel neurokinin receptor antagonist compounds | |
| HK1203938A1 (en) | Novel 2h-indazoles as ep2 receptor antagonists ep2 2h- | |
| HK1192228A1 (zh) | 受體拮抗劑 | |
| EP2765860A4 (en) | Mineralocorticoid receptor antagonists | |
| EP2697203A4 (en) | ANTAGONISTS OF MINERALOCORTICOID RECEPTORS | |
| EP2874621A4 (en) | Mineralocorticoid receptor antagonists | |
| EP2765859A4 (en) | Mineralocorticoid receptor antagonists | |
| EP2765858A4 (en) | ANTAGONISTS OF A MINERALOCORTICOID RECEPTOR | |
| GB201223053D0 (en) | Receptor | |
| GB201213698D0 (en) | Receptor antagonists II | |
| GB201213699D0 (en) | Receptor antagonists II |